Literature DB >> 8666003

beta-Amyloid-(1-40) increases long-term potentiation in rat hippocampus in vitro.

J Wu1, R Anwyl, M J Rowan.   

Abstract

The effect of beta-amyloid-(1-40) was investigated on long-term potentiation of glutamatergic excitatory postsynaptic field potentials recorded in the inner molecular layer in the rat dentate gyrus in vitro. In the presence of 200 nM beta-amyloid-(1-40) there was an increase in long-term potentiation of 51%. Basal synaptic transmission was not affected. These results provide direct evidence that a relatively low concentration of beta-amyloid-(1-40) increases synaptic plasticity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8666003     DOI: 10.1016/0014-2999(95)00539-w

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  20 in total

1.  Administration of aggregated beta-amyloid peptide (25-35) induces changes in long-term potentiation in the hippocampus in vivo.

Authors:  V V Trubetskaya; M Yu Stepanichev; M V Onufriev; N A Lazareva; V A Markevich; N V Gulyaeva
Journal:  Neurosci Behav Physiol       Date:  2003-02

Review 2.  Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections.

Authors:  Wojciech Danysz; Chris G Parsons
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

Review 3.  Alzheimer's disease amyloid beta-protein and synaptic function.

Authors:  Tomas Ondrejcak; Igor Klyubin; Neng-Wei Hu; Andrew E Barry; William K Cullen; Michael J Rowan
Journal:  Neuromolecular Med       Date:  2009-09-16       Impact factor: 3.843

Review 4.  Presenilins and APP in neuritic and synaptic plasticity: implications for the pathogenesis of Alzheimer's disease.

Authors:  Sic L Chan; Katsutoshi Furukawa; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

5.  Involvement of beta-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity.

Authors:  Huifang Ma; Sylvain Lesné; Linda Kotilinek; Jill V Steidl-Nichols; Mathew Sherman; Linda Younkin; Steven Younkin; Colleen Forster; Nicolas Sergeant; André Delacourte; Robert Vassar; Martin Citron; Paulo Kofuji; Linda M Boland; Karen H Ashe
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

6.  Effect of Aggregated β-Amyloid (1-42) on Synaptic Plasticity of Hippocampal Dentate Gyrus Granule Cells in Vivo.

Authors:  Shirin Babri; Mohammad Amani; Gisou Mohaddes; Alireza Alihemmati; Hadi Ebrahimi
Journal:  Bioimpacts       Date:  2012-07-20

7.  Use-dependent effects of amyloidogenic fragments of (beta)-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo.

Authors:  J H Kim; R Anwyl; Y H Suh; M B Djamgoz; M J Rowan
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

Review 8.  Physiological roles of amyloid-beta and implications for its removal in Alzheimer's disease.

Authors:  Glenda M Bishop; Stephen R Robinson
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

9.  The role of beta-amyloid protein in synaptic function: implications for Alzheimer's disease therapy.

Authors:  F Peña; Ai Gutiérrez-Lerma; R Quiroz-Baez; C Arias
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

Review 10.  Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer's disease.

Authors:  Elisa Zuccarello; Erica Acquarone; Elisa Calcagno; Elentina K Argyrousi; Shi-Xian Deng; Donald W Landry; Ottavio Arancio; Jole Fiorito
Journal:  Biochem Pharmacol       Date:  2020-01-21       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.